Find clinical trials in your area

Search by disease and location to discover available clinical trials matching your criteria.

Matched clinical trials

  • Study of visugromab and nivolumab with or without docetaxel as second-line treatment for patients with metastatic non-squamous non-small cell lung cancer

    Recruiting

    1 1
    Germany Italy Poland Romania Spain
  • Study of Rimegepant for Prevention of Menstrual Migraine in Women Aged 18-45 Years

    Recruiting

    1 1 1
    Investigated drugs:
    Denmark Germany Italy The Netherlands Poland Spain
  • Study of zanidatamab in adult patients with HER2-positive solid tumors (endometrial, colorectal, head & neck, sarcoma) or HER2-mutant non-small cell lung cancer

    Recruiting

    1 1
    Investigated drugs:
    France
  • Comparing mirikizumab versus azathioprine with glucocorticoids in newly diagnosed patients with moderate-to-severe ulcerative colitis

    Recruiting

    1 1 1 1
    Investigated drugs:
    Germany
  • Study of BGB-16673 in combination with drug therapy for patients with relapsed or refractory B-cell malignancies

    Recruiting

    1 1 1
    Germany Italy Poland
  • Study of maridebart cafraglutide for patients with heart failure with preserved or mildly reduced ejection fraction and obesity

    Recruiting

    1 1
    Investigated drugs:
    Austria Belgium Bulgaria Czechia Denmark Finland +12
  • Study Comparing the Safety and Effectiveness of Mexiletine PR and Mexiletine IR for Adults with Non-Dystrophic Myotonias

    Recruiting

    1 1 1 1
    Investigated diseases:
    Belgium France Germany Italy
  • Study of milsaperidone as an additional treatment for adults with Major Depressive Disorder who are already taking antidepressants

    Recruiting

    1 1
    Bulgaria Czechia Poland
  • Long-term safety study of tulisokibart in adults with Crohn’s disease or ulcerative colitis

    Recruiting

    1 1
    Investigated drugs:
    Czechia France Hungary Poland
  • Long-term safety study of eptinezumab given by intravenous infusion for children and adolescents aged 6-17 years with chronic or episodic migraine

    Recruiting

    1 1 1 1
    Investigated drugs:
    Italy Poland Portugal Spain